Redwood Ventures — 2009 Investments

1 investments dated 2009 · listed companies and verified rows first · show all

Biocartis Group NVbiocartisgroupnv.beSeries A · Oct 2009 · $15M

Biocartis develops molecular diagnostics and genetic testing solutions for clinical applications.

BiotechDigital HealthMedical DevicesMechelen, BE

Herman Verrelst(Chairman of the board)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.